Compare Moderna, Inc. (MRNA) vs NRG Energy Inc (NRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs NRG Energy Inc — how do they compare? Moderna, Inc. trades at $225 (market cap $78.65B), while NRG Energy Inc trades at $107.97 (market cap $22.35B). The key difference: Moderna, Inc. is far larger — about 3.5× NRG Energy Inc's market cap, and NRG Energy Inc pays a 1.79% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and NRG Energy Inc for 63 Days on average.
| MRNA | NRG | |
|---|---|---|
Market Cap | $78.65B | $22.35B |
Volume | 37,373,437 | 5,011,942 |
Sector | Health | Utilities |
52-Week High | $225.00 | $184.03 |
52-Week Low | $22.36 | $95.23 |
Typical Hold Time | 59 Days | 63 Days |
Enterprise Value | $74.80B | $46.30B |
Dividend Yield | — | 1.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $197.00, up 0.26% today, reflecting a strong 2026 rally. The stock is technically bullish, with moving averages signaling strength and key support at $194. Fundamentally, revenue has declined from pandemic peaks to $1.92 billion in 2025, with net losses widening to -$2.82 billion, though recent quarters have beaten EPS estimates. The company's inclusion in the Nasdaq-100 index effective October 9, 2026, adds a positive catalyst. Analyst sentiment is mixed, with a consensus price target of $115.70 but a high target of $245.00, indicating divergent views on valuation after the stock's significant run-up.
The outlook for Moderna hinges on its pipeline beyond COVID-19, particularly cancer vaccines, but high valuation ratios (P/S of 35.08) and persistent losses pose risks. Upside potential exists if new products gain traction, yet investors face volatility from clinical trial outcomes and competitive pressures. The stock's proximity to 52-week highs suggests caution amid profit-taking signals from some analysts.
NRG Energy trades at $106.32, down 2.11% today, amid mixed earnings results with two recent misses but a Q4 2025 beat. The stock shows a bullish technical signal with support at $104 and resistance at $109. Revenue grew to $30.71 billion in 2025, though net income margin compressed to 2.56%. Recent news highlights a 1.2 GW Texas data center project as a growth driver, while analyst consensus remains strongly bullish with a $202.90 price target.
Outlook is positive due to strong analyst support and strategic investments in data center power, but risks include high debt levels and volatile cash flows. The stock offers potential upside from current levels if execution on new projects meets expectations, though earnings consistency and leverage require monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →
